Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO

被引：0

作者：

Kristeleit, Rebecca ^{[1
]}

O'Malley, David ^{[2
]}

Lim, Myong Cheol ^{[3
]}

Miller, Rowan ^{[4
]}

Herzog, Thomas ^{[5
]}

Wilson, Michelle ^{[6
]}

De Vivo, Rocco ^{[7
]}

Coleman, Robert ^{[8
]}

Oaknin, Ana ^{[9
]}

Oza, Amit ^{[10
]}

Mikheeva, Olga ^{[11
]}

Buscema, Joseph ^{[12
]}

Chudecka-Glaz, Anita ^{[13
]}

Van Le, Linda ^{[14
]}

Van Gorp, Toon ^{[15
]}

Moore, Kathleen ^{[16
]}

Zagouri, Flora ^{[17
]}

Morris, Robert ^{[18
]}

Rob, Lukas ^{[19
,20
]}

Craib, Marcia ^{[21
]}

Connor, Christy ^{[21
]}

Shih, Danny ^{[21
]}

Fujiwara, Keiichi ^{[22
]}

Monk, Bradley ^{[23
,24
,25
]}

机构：

[1] Guys & St Thomas NHS Fdn Trust, London, England

[2] Ohio State Univ, Columbus, OH 43210 USA

[3] Natl Canc Ctr, Goyang Si, Gyeonggi Do, South Korea

[4] Univ Coll London Hosp, London, England

[5] Univ Cincinnati, Cincinnati, OH USA

[6] Auckland City Hosp, Auckland, New Zealand

[7] Osped San Bortolo, Vicenza, Italy

[8] US Oncol Res, Spring, TX USA

[9] Vall dHebron Hosp Univ, Barcelona, Spain

[10] Princess Margaret Hosp, Ctr Canc, Toronto, ON, Canada

[11] Ltd Liabil Co MedPomosch, St Petersburg, Russia

[12] Arizona Oncol Associates, Tucson, AZ USA

[13] Independent Publ Clin Hosp 2 PUM, Szczecin, Poland

[14] Univ North Carolina Chapel Hill, Chapel Hill, NC USA

[15] Univ Ziekenhuizen Leuven, Leuven, Belgium

[16] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA

[17] Alexandra Hosp, Athens, Greece

[18] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA

[19] Charles Univ Prague, Prague, Czech Republic

[20] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic

[21] Pharma&, Broomfield, CO USA

[22] Saitama Med Univ Int Med Ctr, Hidaka, Japan

[23] GOG Fdn, Phoenix, AZ USA

[24] Univ Arizona, Phoenix, AZ USA

[25] Creighton Univ, Omaha, NE 68178 USA

来源：

GYNECOLOGIC ONCOLOGY | 2024年 / 190卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S10 / S11

页数：2

共 50 条

[11] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
Shitara, Kohei
Matsuo, Keitaro
Muro, Kei
Doi, Toshihiko
Ohtsu, Atsushi
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1383 - 1389
[12] Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy
Kohei Shitara
Keitaro Matsuo
Kei Muro
Toshihiko Doi
Atsushi Ohtsu
Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1383 - 1389
[13] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
Terashima, Takeshi
Yamashita, Tatsuya
Takata, Noboru
Nakagawa, Hidetoshi
Toyama, Tadashi
Arai, Kuniaki
Kitamura, Kazuya
Yamashita, Taro
Sakai, Yoshio
Mizukoshi, Eishiro
Honda, Masao
Kaneko, Shuichi
HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
[14] EFFICACY ANALYSIS BY DISEASE RISK SUBGROUP FOR THE PHASE 3 ATHENA-MONO STUDY (GOG3020/ENGOT-OV45) EVALUATING RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH NEWLY DIAGNOSED OVARIAN CANCER
O'Malley, David
Christopoulou, Athina
Lim, Myong Cheol
Diaz, John
Demirkiran, Fuat
Wilson, Michelle
Jewell, Andrea
Drochytek, Vit
Bessette, Paul
Morris, Robert
Van Gorp, Toon
Van Le, Linda
Lindahl, Gabriel
Eskander, Ramez
Collins, Dearbhaile
Goble, Sandra
Hume, Stephanie
Fujiwara, Keiichi
Monk, Bradley
Kristeleit, Rebecca
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A16 - A16
[15] Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Moore, K.
Colombo, N.
Scambia, G.
Kim, B. -G.
Oaknin, A.
Friedlander, M.
Lisyanskaya, A.
Floquet, A.
Leary, A.
Sonke, G. S.
Gourley, C.
Banerjee, S.
Oza, A.
Gonzalez-Martin, A.
Aghajanian, C.
Bradley, W.
Mathews, C.
Liu, J.
Lowe, E. S.
Bloomfield, R.
DiSilvestro, P.
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (26): : 2495 - 2505
[16] Correlation of progression-free and post-progression survival with overall survival in phase III trials of first-line chemotherapy for advanced epithelial ovarian cancer
Shimokawa, M.
Ohki, M.
Kaku, T.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (04) : 370 - 375
[17] CORRELATION OF PROGRESSION-FREE AND POST-PROGRESSION SURVIVAL WITH OVERALL SURVIVAL IN PHASE III TRIALS OF FIRST-LINE CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN CANCER
Shimokawa, M.
Ohki, M.
Kaku, T.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 393 - 393
[18] Treatments for newly diagnosed advanced ovarian cancer: analysis of survival data and cost-effectiveness evaluation
Messori, A
Trippoli, S
Becagli, P
Tendi, E
ANTI-CANCER DRUGS, 1998, 9 (06) : 491 - 502
[19] Overall Survival and Post-Progression Survival in Advanced Breast Cancer: A Review of Recent Randomized Clinical Trials
Saad, Everardo D.
Katz, Artur
Buyse, Marc
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1958 - 1962
[20] The impact of post-progression survival on overall survival of patients with advanced hepatocellular carcinoma treated by sorafenib therapy
Terashima, Takeshi
Yamashita, Tatsuya
Takata, Noboru
Nakagawa, Hidetoshi
Arai, Kuniaki
Kagaya, Takashi
Mizukoshi, Eishiro
Honda, Masao
Kaneko, Shuichi
HEPATOLOGY, 2013, 58 : 1221A - 1221A

← 1 2 3 4 5 →